Algert Global’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$184K Buy
+13,700
New +$204K ﹤0.01% 1258

Other funds holding CTNM

Algert Global's CTNM Position: Q3 2026 in Review

Algert Global opened a new position in Contineum Therapeutics (CTNM) in Q3 2026: 13,700 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #1258 among its holdings.

118 funds tracked by Wall St. Rank hold CTNM as of Q3 2026.

  • Algert Global held 13,700 shares of Contineum Therapeutics worth $184K as of Q3 2026.
  • Contineum Therapeutics was a new Algert Global position in Q3 2026.
  • Contineum Therapeutics made up ﹤0.01% of Algert Global's portfolio in Q3 2026, its #1258 holding.
  • 118 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q3 2026.

Based on Algert Global's 13F filing for Q3 2026, filed 17 Nov 2026.